Heart failure & cardiomyopathies

Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure

Eur J Heart FailPublished Prospective cohort study

Main finding · Incident HFResult — go to the resultHazard ratio per 1 SD increase in log-Prx4 1.22 95% CI 1.09–1.36

Authors' conclusion

Circulating Prx4 associates with the risk of developing HF, both with preserved and reduced ejection fraction.

Study context

Population
Community-based cohort (PREVEND); mean age 49.8 years, 50.1% womenPREVEND cohort
Participants
8,199 participants
Exposure
Higher vs lower circulating Prx4
Outcome
Incident HF and its subtypes (HFpEF, HFrEF)
Follow-up
Median 12.6 years
Methodological detailscommunity-based
  • Community-based

Main finding

Incident HF

Hazard ratio per 1 SD increase in log-Prx4

1.22

95% CI 1.09–1.36

P < 0.001

Highervs lower circulating Prx4 (per 1 SD increase in log-Prx4)
HR per 1 SD increase in log-Prx4 1.22 (95% CI 1.09–1.36); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Incident heart failure (HF) by subtype (HFpEF, HFrEF)

HR (95% CI)
Prx4HFpEF1.27 (1.05–1.53)
Prx4HFrEF1.19 (1.04–1.37)
Incident HF by subtype (HFpEF, HFrEF) — HFpEF events
118 (33.8%)
Incident HF by subtype (HFpEF, HFrEF) — No significant difference between subtypes
p = 0.64

Original publication

Peroxiredoxin-4, a Marker of Systemic Oxidative Stress, is Associated with Incident Heart Failure. Eur J Heart Fail. Published 6 April 2025. doi:10.1002/ejhf.3653

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.